Stockscreener 앱 받기
1.95
6.25%
-0.13
시간 외 거래:
1.97
0.02
+1.03%
전일 마감가:
$2.08
열려 있는:
$2.06
하루 거래량:
1.50M
Relative Volume:
1.60
시가총액:
$276.01M
수익:
$744.00K
순이익/손실:
$-159.24M
주가수익비율:
-3.5813
EPS:
-0.5445
순현금흐름:
$-146.73M
1주 성능:
-12.95%
1개월 성능:
-10.96%
6개월 성능:
-27.24%
1년 성능:
+96.77%
1일 변동 폭
$1.87
$2.10
1주일 범위
$1.87
$2.37
52주 변동 폭
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
명칭
Prokidney Corp
전화
336-999-7028
주소
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Compare PROK vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
1.95 | 294.41M | 744.00K | -159.24M | -146.73M | -0.5445 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | H.C. Wainwright | Buy |
| 2025-06-30 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-09-30 | 개시 | JP Morgan | Neutral |
| 2024-09-10 | 개시 | Guggenheim | Buy |
| 2024-03-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-07-25 | 개시 | BTIG Research | Buy |
| 2022-12-21 | 개시 | Jefferies | Buy |
| 2022-11-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-18 | 개시 | UBS | Buy |
| 2022-10-14 | 개시 | Citigroup | Buy |
| 2022-09-23 | 개시 | BofA Securities | Buy |
| 2022-09-02 | 개시 | Evercore ISI | Outperform |
모두보기
Prokidney Corp 주식(PROK)의 최신 뉴스
ProKidney ends fiscal 2025 with bigger loss, larger revenue stream - Winston-Salem Journal
ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating - TipRanks
ProKidney (NASDAQ:PROK) Raised to "Strong-Buy" at Jefferies Financial Group - MarketBeat
ProKidney Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
BofA reiterates ProKidney stock Underperform rating at $1 target - Investing.com
ProKidney (NASDAQ:PROK) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
ProKidney Reports Full Year 2025 Financial Results and Business Highlights - Bitget
PROK: FDA alignment, strong clinical progress, and cash runway into 2027 despite ongoing losses - TradingView
ProKidney (Nasdaq: PROK) details 2025 loss and cash runway into 2027 - Stock Titan
ProKidney (PROK) advances Phase 3 rilparencel program for diabetic CKD - Stock Titan
Cell therapy for kidney disease targets key FDA data by Q2 2027 - Stock Titan
ProKidney’s High Cash Usage Dims Pipeline Hopes—Investors Brace for Funding Shortfall Before 2027 Results - Bitget
ETF Watch: How volatile is ProKidney Corp stock2026 PreEarnings & Entry and Exit Point Strategies - baoquankhu1.vn
Aug Update: Why is ProKidney Corp stock going downRisk Management & AI Powered Market Entry Ideas - baoquankhu1.vn
ProKidney (NASDAQ:PROK) Stock Price Down 4.7%Time to Sell? - MarketBeat
Dividend Watch: Is ProKidney Corp stock undervalued right now2026 Update & Real-Time Price Movement Reports - baoquankhu1.vn
ProKidney’s Unclear Messages Leave Traders Puzzled - Bitget
Portfolio Shifts: Is ProKidney Corp impacted by rising ratesOptions Play & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Meet the Biotech Stock That Rocketed 775% Higher - MSN
Prokidney Corp expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Momentum Shift: Is ProKidney Corp stock undervalued right nowWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
ProKidney (PROK) Projected to Post Earnings on Monday - MarketBeat
ProKidney, FDA align on accelerated approval pathway for Rilparencel - MSN
Can ProKidney Corp. stock hit record highs again2026 Fundamental Recap & Safe Entry Zone Tips - Naître et grandir
Why ProKidney Corp. stock could outperform in 2026Rate Cut & AI Enhanced Trading Alerts - Naître et grandir
Smart Money: Is ProKidney Corp impacted by rising rates2025 AllTime Highs & Breakout Confirmation Trade Signals - baoquankhu1.vn
Wall Street Recap: Does ProKidney Corp offer margin of safetyQuarterly Portfolio Review & Long-Term Safe Investment Ideas - baoquankhu1.vn
ProKidney (NASDAQ:PROK) Stock Price Up 9%Here's Why - MarketBeat
PROKIDNEY CORP. (PROK) CFO awarded 600,000-share stock option grant - Stock Titan
ProKidney (NASDAQ: PROK) awards 400,000 stock options to Chief Regulatory Officer - Stock Titan
ProKidney (PROK) grants CLO Todd Girolamo 600,000 stock options - Stock Titan
ProKidney (NASDAQ: PROK) CEO awarded stock options on 3,000,000 shares - Stock Titan
PROK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PROK Should I Buy - Intellectia AI
ProKidney Corp. (NASDAQ:PROK) Given Average Rating of "Hold" by Analysts - MarketBeat
Forecast Cut: Is ProKidney Corp impacted by rising ratesPortfolio Update Report & Verified Short-Term Plans - baoquankhu1.vn
Moving Averages: Should value investors consider ProKidney CorpJuly 2025 Short Interest & Reliable Trade Execution Plans - baoquankhu1.vn
How ProKidney Corp. stock reacts to job market dataGDP Growth & Technical Pattern Based Signals - mfd.ru
CEO Change: Whats the outlook for ProKidney Corps sectorJuly 2025 Analyst Calls & Intraday High Probability Alerts - baoquankhu1.vn
What’s the outlook for ProKidney Corp.’s sectorWeekly Risk Report & Fast Gain Swing Alerts - mfd.ru
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth - MSN
Why is ProKidney Corp. stock going downWeekly Stock Recap & Intraday High Probability Alerts - mfd.ru
Can ProKidney Corp. continue delivering strong returnsJuly 2025 Earnings & Verified Chart Pattern Signals - mfd.ru
Morgan Stanley discloses 6% ProKidney (PROK) stake in Schedule 13G - Stock Titan
3 Promising Penny Stocks With At Least $600M Market Cap - simplywall.st
Will ProKidney Corp. benefit from seasonalityMarket Activity Summary & High Conviction Trade Alerts - mfd.ru
Can ProKidney Corp. be the next market leader2025 Earnings Impact & Advanced Swing Trade Entry Alerts - mfd.ru
Will ProKidney Corp. benefit from green energy policiesWeekly Trading Summary & Reliable Breakout Stock Forecasts - mfd.ru
Is ProKidney Corp. stock a top performer YTDInflation Watch & Free Reliable Trade Execution Plans - mfd.ru
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - 富途牛牛
Revenue Check: Will ProKidney Corp benefit from geopolitical trendsBreakout Watch & Weekly High Return Forecasts - baoquankhu1.vn
Prokidney Corp (PROK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):